siRNA treatment reduces triglycerides in patients along with uncommon disorder

.STUDY EMPHASIZE.19 September 2024.

Plozasiran decreased triglyceride levels by 80% and also reduced the risk of pancreatitis in people along with persistent chylomicronemia, along with or even without a genetic diagnosis.

Articles You Can Be Interested In

• Personal Finance
• Social Media
• Charity
• Mindfulness
• Leadership
• Weddings
• PR & Branding
• Credit
• Education
• Mindfulness
• Philosophy
• Pets
• Teamwork
• Insurance
• Mobile Tech
• PR & Branding
• Healthcare
• Robotics
• Gardening
• Public Policy